knowledge -WSS

knowledge

author：Wikipedia 2025-08-28 13:07:26 - browse：23352

Adam's take main illustration — Molly Ferguson/STAT

This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks.

A Worst CEO gets some much-needed help

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for degenerative eye diseases. The deal never happened. I heard from many Ocular investors who were frustrated and angry about Mattesich’s poor job performance. He ended up earning a spot last year on my worst biopharma CEO list. It was an easy pick.

On Thursday, Ocular announced a meaningful “leadership update.” Mattessich is still the CEO, but let’s just say the company’s board decided to surround him with new executives and retinal experts with proven track records of getting stuff done.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： ASCO Takeaways: Winners, snoozers, and the art of cancer care

entertainment

WSS

Wearables generate powerful data but its not useful to doctors, yet

Stopping antidepressants leads to symptoms for 1 in 6 patients

NVIDIA and Google execs on the future of AI and drug discovery

It's time to retire 'poor historian' from clinicians' vocabularies

Helping hospitals and community health centers plan for resilience

Arc Institute generative AI designs new CRISPR systems

hotspot

knowledge

A Worst CEO gets some much-needed help

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Drug repurposing or repositioning? The language matters

How CO2 helps viruses stay alive longer in the air

How to save PrEP access — and even expand it

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Cancer drug shortages should be causing more outrage

Military medical care influenced by rank and race, new study finds

leisure time

Venture capitalist Bob Kocher on the state of digital health

With measles on the rise, a personal story of a devastating disease

An outdated Medicare rule harms dementia patients with anxiety

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Anthony Fauci pushes back on GOP claims during Covid hearing

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

entertainment

entertainment

entertainment

focus